ALLcrimesfood&drugstaxestelecomcommercehealthconservationtransportationagricultureveteransbrowse all titles »
0

42 U.S.C. § 284Directors of national research institutes

submitted 82 years ago by Pub. L. 99-158 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE · 1,424 words · no verdicts yet

in plain englishAI-generated · not legal advice

This law explains how NIH's national research institutes get their Directors. The President appoints the Cancer Institute's Director; the Secretary appoints the rest for 5-year terms. It also spells out each Director's duties, grant powers, and required coordination with other institutes.

(a) Appointment The President appoints the Director of the National Cancer Institute. The Secretary, acting through the Director of NIH, appoints the Directors of all the other national research institutes and centers. Every institute or center Director reports directly to the Director of NIH. A Director the Secretary appoints serves a 5-year term. At the end of that term, the Director can be reappointed under the standards that normally apply to that kind of appointment, and there's no limit on how many terms a Director may serve. If a Director's office becomes vacant before the term ends, whoever fills it serves a full new 5-year term starting from the appointment date. Any Director already serving as of December 13, 2016 is treated as having started a new 5-year term on that date. None of this limits the Secretary's or the NIH Director's power to remove a Director before the 5-year term ends. Appointments and reappointments must be based on ability and experience relevant to NIH's mission, including meeting any legal requirements the Secretary or NIH Director thinks matter. A specific 1993 law restriction on hiring short-term consultants and scientists does not apply to Directors appointed this way. (b) Duties and authority; grants, contracts, and cooperative agreements To carry out NIH's mission on human diseases, disorders, and health, the Secretary, acting through each institute's Director: must encourage and support research on maintaining health; detecting, diagnosing, treating, and preventing disease; rehabilitating people with diseases, disorders, and disabilities; and expanding knowledge of how diseases and the body work, and how people interact with their environment; may conduct that research itself, subject to required peer review and any advisory-council review; must, where appropriate, support research that could transform the field, that carries higher risk, and that tackles major current challenges; may support research training, other than fellowships funded elsewhere or medical residency training; may develop and support programs that apply research results to clinical practice and disease prevention; may develop public and professional education and information programs; may build and maintain the resources research needs; may open institute facilities to appropriate researchers, and help federal and state public-health agencies; may accept unconditional gifts, and build a memorial for donors giving over $50,000; may hire consultants from the U.S. or abroad; may use other federal, state, or local agencies' services, equipment, staff, information, and facilities, with their consent, with or without paying them; may accept volunteer, unpaid help; and may do other things the Secretary decides are needed to carry out the institute's purpose. Certain federal indemnification rules for contractors apply to contracts made under this power. Grants, contracts, and cooperative agreements funding this work must first pass technical and scientific peer review. Grants and cooperative agreements up to $50,000 also need that peer review; ones over $50,000 need that peer review plus the relevant advisory council's recommendation. Each institute director must also, subject to certain accounting rules, receive its full congressional appropriation directly from the President and the Office of Management and Budget. Before awarding a new competitive research-program grant ("R-series grant") — not a routine renewal or supplement — the institute or center Director must personally review it, make the final award decision, and consider, as appropriate: the institute's mission and the priorities in its strategic plan; similar research other agencies are already funding; and advice from staff and the advisory council or board. (c) Coordination with other public and private entities; cooperation with other national research institutes; appointment of additional peer review groups In doing this work, each institute Director must coordinate, where appropriate, with similar programs run by other public and private groups, and cooperate with other institute Directors on multidisciplinary or multi-institute research. With the advisory council's input and the NIH Director's approval, an institute Director may also set up extra technical and scientific peer review groups beyond the ones NIH's Director already appoints, and choose their members. Directors may also publish, or arrange to publish, information about their institute's purpose without needing the usual government-printing approval. Federal rules limiting how long advisory committees may exist don't apply to these extra peer review groups.
the actual law source: uscode.house.gov ↗public domain
(a) Appointment
(1) In general

The Director of the National Cancer Institute shall be appointed by the President, and the Directors of the other national research institutes and national centers shall be appointed by the Secretary, acting through the Director of National Institutes of Health. Each Director of a national research institute or national center shall report directly to the Director of National Institutes of Health.

(2) Appointment
(A) Term

A Director of a national research institute or national center who is appointed by the Secretary, acting through the Director of National Institutes of Health, shall be appointed for 5 years.

(B) Reappointment

At the end of the term of a Director of a national research institute or national center, the Director may be reappointed in accordance with standards applicable to the relevant appointment mechanism. There shall be no limit on the number of terms that a Director may serve.

(C) Vacancies

If the office of a Director of a national research institute or national center becomes vacant before the end of such Director’s term, the Director appointed to fill the vacancy shall be appointed for a 5-year term starting on the date of such appointment.

(D) Current directors

Each Director of a national research institute or national center who is serving on December 13, 2016, shall be deemed to be appointed for a 5-year term under this subsection beginning on such date.

(E) Rule of construction

Nothing in this subsection shall be construed to limit the authority of the Secretary or the Director of National Institutes of Health to terminate the appointment of a director referred to in subparagraph (A) before the expiration of such director’s 5-year term.

(F) Nature of appointment

Appointments and reappointments under this subsection shall be made on the basis of ability and experience as it relates to the mission of the National Institutes of Health and its components, including compliance with any legal requirement that the Secretary or Director of National Institutes of Health determines relevant.

(3) Nonapplication of certain provision

The restrictions contained in section 202 of the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 1993 (Public Law 102–394; 42 U.S.C. 238f note) related to consultants and individual scientists appointed for limited periods of time shall not apply to Directors appointed under this subsection.

(b) Duties and authority; grants, contracts, and cooperative agreements
(1)

In carrying out the purposes of section 241 of this title with respect to human diseases or disorders or other aspects of human health for which the national research institutes were established, the Secretary, acting through the Director of each national research institute—

(A)

shall encourage and support research, investigations, experiments, demonstrations, and studies in the health sciences related to—

(i)

the maintenance of health,

(ii)

the detection, diagnosis, treatment, and prevention of human diseases and disorders,

(iii)

the rehabilitation of individuals with human diseases, disorders, and disabilities, and

(iv)

the expansion of knowledge of the processes underlying human diseases, disorders, and disabilities, the processes underlying the normal and pathological functioning of the body and its organ systems, and the processes underlying the interactions between the human organism and the environment;

(B)

may, subject to the peer review prescribed under section 289a(b) of this title and any advisory council review under section 284a(a)(3)(A)(i) of this title, conduct the research, investigations, experiments, demonstrations, and studies referred to in subparagraph (A);

(C)

shall, as appropriate, conduct and support research that has the potential to transform the scientific field, has inherently higher risk, and that seeks to address major current challenges;

(D)

may conduct and support research training (i) for which fellowship support is not provided under section 288 of this title, and (ii) which is not residency training of physicians or other health professionals;

(E)

may develop, implement, and support demonstrations and programs for the application of the results of the activities of the institute to clinical practice and disease prevention activities;

(F)

may develop, conduct, and support public and professional education and information programs;

(G)

may secure, develop and maintain, distribute, and support the development and maintenance of resources needed for research;

(H)

may make available the facilities of the institute to appropriate entities and individuals engaged in research activities and cooperate with and assist Federal and State agencies charged with protecting the public health;

(I)

may accept unconditional gifts made to the institute for its activities, and, in the case of gifts of a value in excess of $50,000, establish suitable memorials to the donor;

(J)

may secure for the institute consultation services and advice of persons from the United States or abroad;

(K)

may use, with their consent, the services, equipment, personnel, information, and facilities of other Federal, State, or local public agencies, with or without reimbursement therefor;

(L)

may accept voluntary and uncompensated services; and

(M)

may perform such other functions as the Secretary determines are needed to carry out effectively the purposes of the institute.

The indemnification provisions of section 3861 of title 10 shall apply with respect to contracts entered into under this subsection and section 282(b) of this title.

(2)

Support for an activity or program under this subsection may be provided through grants, contracts, and cooperative agreements. The Secretary, acting through the Director of each national research institute—

(A)

may enter into a contract for research, training, or demonstrations only if the contract has been recommended after technical and scientific peer review required by regulations under section 289a of this title;

(B)

may make grants and cooperative agreements under paragraph (1) for research, training, or demonstrations, except that—

(i)

if the direct cost of the grant or cooperative agreement to be made does not exceed $50,000, such grant or cooperative agreement may be made only if such grant or cooperative agreement has been recommended after technical and scientific peer review required by regulations under section 289a of this title, and

(ii)

if the direct cost of the grant or cooperative agreement to be made exceeds $50,000, such grant or cooperative agreement may be made only if such grant or cooperative agreement has been recommended after technical and scientific peer review required by regulations under section 289a of this title and is recommended under section 284a(a)(3)(A)(ii) of this title by the advisory council for the national research institute involved; and

(C)

shall, subject to section 300cc–40c(d)(2) of this title, receive from the President and the Office of Management and Budget directly all funds appropriated by the Congress for obligation and expenditure by the Institute.

(3)

Before an award is made by a national research institute or by a national center for a grant for a research program or project (commonly referred to as an “R-series grant”), other than an award constituting a noncompetitive renewal of such a grant, or a noncompetitive administrative supplement to such a grant, the Director of such national research institute or national center shall, consistent with the peer review process—

(A)

review and make the final decision with respect to making the award; and

(B)

take into consideration, as appropriate—

(i)

the mission of the national research institute or national center and the scientific priorities identified in the strategic plan under section 282(m) of this title;

(ii)

programs or projects funded by other agencies on similar research topics; and

(iii)

advice by staff and the advisory council or board of such national research institute or national center.

(c) Coordination with other public and private entities; cooperation with other national research institutes; appointment of additional peer review groups

In carrying out subsection (b), each Director of a national research institute—

(1)

shall coordinate, as appropriate, the activities of the institute with similar programs of other public and private entities;

(2)

shall cooperate with the Directors of the other national research institutes in the development and support of multidisciplinary research and research that involves more than one institute;

(3)

may, in consultation with the advisory council for the Institute and with the approval of the Director of NIH

(A)

establish technical and scientific peer review groups in addition to those appointed under section 282(b)(16) of this title; and

(B)

appoint the members of peer review groups established under subparagraph (A); and

(4)

may publish, or arrange for the publication of, information with respect to the purpose of the Institute without regard to section 501 of title 44.

Chapter 10 of title 5 shall not apply to the duration of a peer review group appointed under paragraph (3).

Source credit: (July 1, 1944, ch. 373, title IV, § 405, as added Pub. L. 99–158, § 2, Nov. 20, 1985, 99 Stat. 826; amended Pub. L. 100–607, title I, § 116, Nov. 4, 1988, 102 Stat. 3053; Pub. L. 100–690, title II, § 2613(c), Nov. 18, 1988, 102 Stat. 4239; Pub. L. 103–43, title III, § 301(a)(1), (b), June 10, 1993, 107 Stat. 150; Pub. L. 109–482, title I, § 102(f)(1)(B), Jan. 15, 2007, 120 Stat. 3685; Pub. L. 114–255, div. A, title II, §§ 2033(a), (b), 2036(c), Dec. 13, 2016, 130 Stat. 1057, 1058, 1063; Pub. L. 117–81, div. A, title XVII, § 1702(j)(1)(B), Dec. 27, 2021, 135 Stat. 2159; Pub. L. 117–286, § 4(a)(232), Dec. 27, 2022, 136 Stat. 4331.)

history & why it existsrecord from the source credit
  • 1944Enacted · Pub. L. 99-158 · 99 Stat. 826
  • 1988Amended · Pub. L. 100-607 · 102 Stat. 3053
  • 1988Amended · Pub. L. 100-690 · 102 Stat. 4239
  • 1993Amended · Pub. L. 103-43 · 107 Stat. 150
  • 2007Amended · Pub. L. 109-482 · 120 Stat. 3685
  • 2016Amended · Pub. L. 114-255 · 130 Stat. 1057, 1058, 1063
  • 2021Amended · Pub. L. 117-81 · 135 Stat. 2159
  • 2022Amended · Pub. L. 117-286 · 136 Stat. 4331

A history note hasn’t been published yet. The record shows enactment by Pub. L. 99-158 on 1944-07-01.

all 0 arguments · sorted by: best

0/280

no arguments yet — make the first case